Detalles de la búsqueda
1.
Relative vaccine effectiveness against COVID-19 hospitalisation in persons agedâ¯≥â¯65â¯years: results from a VEBIS network, Europe, October 2021 to July 2023.
Euro Surveill
; 29(1)2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179626
2.
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥â¯60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023.
Euro Surveill
; 29(3)2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240061
3.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill
; 29(13)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551095
4.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Euro Surveill
; 29(8)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390651
5.
Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022.
Euro Surveill
; 28(5)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36729113
6.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997666
7.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill
; 28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997665
8.
Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022.
Euro Surveill
; 27(33)2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983774
9.
Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22.
Euro Surveill
; 27(26)2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35775428
10.
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022.
Euro Surveill
; 27(30)2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904059
11.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Euro Surveill
; 27(21)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35620997
12.
Effect of Influenza Vaccination in Preventing Laboratory-Confirmed Influenza Hospitalization in Patients With Diabetes Mellitus.
Clin Infect Dis
; 73(1): 107-114, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32412600
13.
Effect of influenza vaccination in patients with asthma.
CMAJ
; 193(29): E1120-E1128, 2021 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34312165
14.
Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination.
Euro Surveill
; 26(32)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387185
15.
Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021.
Euro Surveill
; 26(21)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34047271
16.
Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021.
Euro Surveill
; 26(39)2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34596016
17.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Euro Surveill
; 26(29)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34296676
18.
Recapture of patients with an incomplete diagnosis of hepatitis C virus infection.
Rev Esp Enferm Dig
; 112(7): 525-531, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32515981
19.
Remaining Effect of Influenza Vaccines Received in Prior Seasons.
J Infect Dis
; 220(7): 1136-1140, 2019 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31107953
20.
Health-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population.
Qual Life Res
; 28(6): 1477-1484, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666549